Literature DB >> 10877227

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

J R Korzenik1, B K Dieckgraefe.   

Abstract

The current hypothesis for the etiology of Crohn's disease proposes an excessive immune response, largely T-cell driven, possibly against endogenous bacteria. Standard therapy is therefore directed towards suppression of this immune response. An alternative theory of pathogenesis accounts for epidemiologic and pathophysiologic observations that have been hitherto underemphasized, namely, (1) genetic disorders with deficiencies in neutrophil function can give rise to a clinical and pathologic syndrome indistinguishable from Crohn's; (2) abnormal neutrophil function is well described in Crohn's disease; (3) a group of bacteria implicated in other chronic inflammatory disorders causes impairment of neutrophil function; and (4) 20th century environmental risk factors for Crohn's disease may directly suppress neutrophil function and may have led to a shift in the dominant gut flora with similar effects. We propose that some cases of Crohn's disease result from the interaction of environmental and genetic influences leading to impaired mucosal neutrophil function, resulting in failure to effectively clear intramucosal microbes effectively. While encompassing existing data, this hypothesis proposes a proximate defect in the mucosal immune response. If this paradigm were correct, new therapeutic approaches might involve strategies to alter intestinal flora and stimulate neutrophil function.

Entities:  

Mesh:

Year:  2000        PMID: 10877227     DOI: 10.1023/a:1005541700805

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  91 in total

1.  Abnormal technetium labelled white cell scan in the colitis of chronic granulomatous disease.

Authors:  S Hoare; J E Walsh; E Eastham; M A Abinun; A J Cant
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

2.  Immunological studies on Crohn's disease. VIII. Diminished phagocytic activity in peripheral blood monocytes.

Authors:  N Okabe; S Ikura; Y Uchida; K Fujita; T Yao
Journal:  J Clin Lab Immunol       Date:  1990-05

3.  Defective polymorphonuclear chemotaxis in patients with Turner's syndrome (45,X).

Authors:  M López-Osuna; E Vega-Avila; F Salamanca; R R Kretschmer
Journal:  Clin Genet       Date:  1988-09       Impact factor: 4.438

4.  Neutrophil dysfunction in Crohn's disease.

Authors:  A W Segal; G Loewi
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

5.  Diet and the faecal microflora of infants, children and adults in rural Nigeria and urban U.K.

Authors:  A M Tomkins; A K Bradley; S Oswald; B S Drasar
Journal:  J Hyg (Lond)       Date:  1981-06

6.  Influence of breast-feeding on the bifid flora of the newborn intestine.

Authors:  H Beerens; C Romond; C Neut
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

7.  Refractory periodontitis: mixed infection with Bacteroides gingivalis and other unusual Bacteroides species. A case report.

Authors:  T E Van Dyke; S Offenbacher; D Place; V R Dowell; J Jones
Journal:  J Periodontol       Date:  1988-03       Impact factor: 6.993

8.  Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

9.  Inflammatory bowel disease in glycogen storage disease type Ib.

Authors:  T F Roe; D W Thomas; V Gilsanz; H Isaacs; J B Atkinson
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

10.  Candidacidal activity of Crohn's disease neutrophils.

Authors:  F T Curran; D J Youngs; R N Allan; M R Keighley
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more
  29 in total

1.  Gastrointestinal Manifestations of Non-AIDS Immunodeficiency.

Authors:  Robert P. McCabe
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

Review 2.  Biologics in inflammatory bowel disease: how much progress have we made?

Authors:  W J Sandborn; W A Faubion
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

3.  Is Crohn's disease due to defective immunity?

Authors:  J R Korzenik
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 4.  The immunopathogenesis of Crohn's disease: a three-stage model.

Authors:  Gavin W Sewell; Daniel Jb Marks; Anthony W Segal
Journal:  Curr Opin Immunol       Date:  2009-08-08       Impact factor: 7.486

5.  Colitis and colony-stimulating factors (CSFs): is stimulation of innate immunity through CSFs really effective for the treatment of chronic colitis?

Authors:  Kazuyoshi Nagayama; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

6.  Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn's disease.

Authors:  Juan Carlos Andreu-Ballester; Victoria Amigó-García; Ignacio Catalán-Serra; Rafael Gil-Borrás; Ferrán Ballester; Amadeo Almela-Quilis; Monica Millan-Scheiding; Carlos Peñarroja-Otero
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

Review 7.  Etiology of inflammatory bowel disease: a unified hypothesis.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

8.  Sargramostim in patients with Crohn's disease: results of a phase 1-2 study.

Authors:  Masakazu Takazoe; Toshiyuki Matsui; Satoshi Motoya; Takayuki Matsumoto; Toshifumi Hibi; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-04-08       Impact factor: 7.527

9.  Heterozygous nucleotide-binding oligomerization domain-2 mutations affect monocyte maturation in Crohn's disease.

Authors:  Marilena Granzotto; Elisa Fabbro; Massimo Maschio; Stefano Martelossi; Sara Quaglia; Alberto Tommasini; Gianni Presani; Alessandro Ventura
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

10.  Biologic targeting in the treatment of inflammatory bowel diseases.

Authors:  Matteo Bosani; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.